文献速递哮喘

性别对临床风险因素与2型生物标志物预测哮喘发作的影响

Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers.
PubMed 文献 · Chest · 2026-01-31

该研究对22项随机哮喘试验对照组共6,510例患者进行患者水平荟萃分析,比较性别对临床特征、血嗜酸性粒细胞计数(BEC)和呼出气一氧化氮(Feno)预测重症哮喘发作的影响。女性年化发作率高于男性(0.90 vs 0.74次/患者年),既往发作史在男性中预测价值更强,其他因素及2型生物标志物无显著性别差异。

要点

  • 女性哮喘患者年化重症发作率高于男性。
  • 既往发作史为两性最强预测因子,但男性风险比更高。
  • 高BEC合并高Feno组两性风险均最高。

核心结论

  • 女性年化哮喘发作率高于男性,既往发作史对男性预测价值更强,其他临床风险因素和2型生物标志物无显著性别差异。

研究设计与样本

  • 对22项随机哮喘试验对照组进行患者水平荟萃分析(ORACLE2),共纳入6,510例患者(女性4,140例,男性2,370例)。

主要发现

  • 粗发作率女性为0.90次/患者年,男性为0.74次/患者年。
  • 治疗强度、BMI、肺功能、吸烟状态、合并症及2型生物标志物的预后价值在两性间相似。
  • 两性中高BEC合并高Feno组风险最高。

临床怎么用

  • 评估哮喘发作风险时应考虑性别差异,尤其对无既往发作史的女性患者可能需加强关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple clinical and inflammatory risk factors for asthma attacks have been identified, including attack history, comorbidities, blood eosinophil count (BEC), and exhaled nitric oxide (Feno). However, the impact of sex on their prognostic value is unclear. RESEARCH QUESTION: Does sex modify prognostic values of clinical characteristics, BEC, and Feno for severe asthma attacks? STUDY DESIGN AND METHODS: We conducted a patient-level meta-analysis of the control arms of 22 randomized asthma trials (Oxford Asthma Attack Risk Scale Meta-Analysis [ORACLE2], N = 6,510). Annualized severe asthma attack rates and (adjusted) rate ratios (aRRs) (95% CI) were estimated with sex-specific multivariable negative binomial models, adjusting for baseline demographics, clinical characteristics, and type 2 biomarkers (BEC and Feno). Interaction tests evaluated the influence of sex on other prognostic factors. RESULTS: Among 4,140 female and 2,370 male patients, crude attack rates were higher in female patients than in male patients (0.90 vs 0.74 attacks/patient-year). Prior asthma attacks were the strongest predictor of future attacks in both sexes but with a higher aRR in male individuals (aRR [95%CI], 2.76 [1.97-3.88]) than in female individuals (1.66 [1.33-2.06]; interaction P = .03). In contrast, the prognostic utility of treatment intensity, BMI, lung function, smoking status, comorbidities, and type 2 biomarkers was similar in male and female individuals. The highest risk was seen in the combined high-BEC/high- Feno groups for both sexes. INTERPRETATION: To our knowledge, this study is the first patient-level meta-analysis of prospectively collected clinical trial data to evaluate sex as a modifier of prognostic factors for asthma attacks. The overall annualized asthma attack rate was higher in female than male individuals. Prior attack history had stronger prognostic value for future attacks in male individuals, whereas other clinical risk factors and type 2 biomarkers (blood eosinophils and Feno) showed no major sex differences. These findings highlight that female individuals without prior attacks may face increased risk, and they have important implications for clinical research and practice.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Riemann, Meulmeester, Mailhot-Larouche, et al. Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers. Chest. 2026. PMID: 41621639. doi:10.1016/j.chest.2025.12.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。